Skip to content
2000
  • ISSN: 1568-0088
  • E-ISSN: 1875-5917

Abstract

Osteoclasts are the sole bone resorbing cells. These cells are essential for skeletal development and remodeling throughout the life of animal and man. Deficiency of osteoclasts leads to osteopetrosis, a diseases manifested by increased non-remodeled bone mass, which ultimately leads to bone deformities and functional failure of other body systems. On the other hand, increased number and activity of osteoclasts under certain pathologic conditions causes accelerated bone resorption and may lead to osteoporosis and osteolytic diseases. To better understand the mechanisms underlying osteoclast- based diseases and design relevant therapies, one should unveil the molecular basis of osteoclast differentiation and function and regulatory mechanisms of osteoclast signaling. This review will outline up-to-date information regarding osteoclast differentiation and activation. Molecular mechanisms underlying osteoclast signaling pathways in inflammatory osteolysis and arthritis will be discussed. In addition, stimulators and inhibitors of osteoclasts, as well as current therapies for osteoclast activity will be addressed.

Loading

Article metrics loading...

/content/journals/cdtiemd/10.2174/1568008054863808
2005-09-01
2025-05-28
Loading full text...

Full text loading...

/content/journals/cdtiemd/10.2174/1568008054863808
Loading

  • Article Type:
    Review Article
Keyword(s): bone resorption; nf-kb; opg; osteoclast; rank ligand; stat; tnf; traf
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test